Princeton Global Asset Management’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Princeton Global Asset Management's DGX Position: Q2 2026 in Review
Princeton Global Asset Management reduced its Quest Diagnostics (DGX) stake by 1.4% in Q2 2026, selling an estimated $1.57K and leaving 570 shares worth $121K. The position accounts for 0.02% of the portfolio, ranked #273.
Princeton Global Asset Management first reported a position in DGX in Q1 2020 and has held it in 26 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Princeton Global Asset Management held 570 shares of Quest Diagnostics worth $121K as of Q2 2026.
- Princeton Global Asset Management sold 8 Quest Diagnostics shares in Q2 2026, an estimated $1.57K.
- Quest Diagnostics made up 0.02% of Princeton Global Asset Management's portfolio in Q2 2026, its #273 holding.
- Princeton Global Asset Management first reported a position in Quest Diagnostics in Q1 2020 and has held it in 26 quarters since.
- 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Princeton Global Asset Management's 13F filing for Q2 2026, filed 16 Jul 2026.